Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$22.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 48 most recent Form 4 transactions.
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 4.5M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | XXITM◆ | 484,395 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 1.6M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 200,000 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 1.9M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 2.4M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 1.2M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | XXITM◆ | 1.9M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 6.6M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 600,142 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 544,162 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 1.3M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 4.6M | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | PBUY | 200,000 | $18.00 | $3.6M | +24.5% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | SSELL | 438 | $18.00 | $7.9K | <0.1% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | XXITM | 78,656 | — | — | +10.7% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 273,527 | — | — | +59.1% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 463,106 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | PBUY | 133,333 | $18.00 | $2.4M | +30.2% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | SSELL | 277 | $18.00 | $5K | <0.1% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | XXITM | 49,850 | — | — | +12.7% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 166,168 | — | — | +73.8% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 20,582 | — | — | +10.1% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 204,658 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 255,823 | — | — | +215.9% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 118,512 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | PBUY | 222,222 | $18.00 | $4M | +13.8% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | SSELL | 1,065 | $18.00 | $19.2K | <0.1% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | XXITM | 191,541 | — | — | +13.5% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 683,817 | — | — | +93.0% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 61,762 | — | — | +9.2% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 59,692 | — | — | +9.7% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 139,366 | — | — | +29.4% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 474,048 | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 9.4M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 6.8M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 9.4M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 27.3M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | PBUY | 277,777 | $18.00 | $5M | +32.9% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 489,486 | — | — | +137.9% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 354,824 | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | PBUY | 277,778 | $18.00 | $5M | +14.5% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 489,486 | — | — | +34.5% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 1.4M | — | — | — | Open the original filing on SEC.gov |
| Oct 9, 2025 | ZBIO | Zenas BioPharma, Inc. | PBUY | 63,157 | $19.00 | $1.2M | +3.4% | Open the original filing on SEC.gov |
| Oct 9, 2025 | ZBIO | Zenas BioPharma, Inc. | PBUY | 63,158 | $19.00 | $1.2M | +5.7% | Open the original filing on SEC.gov |